ピーナッツアレルギー治療市場規模、シェア、動向分析レポート：薬剤クラス別、投与経路別、流通チャネル別、地域別、セグメント予測、2025年～2033年

ピーナッツアレルギー治療市場の成長と動向：

Grand View Research社の最新レポートによると、世界のピーナッツアレルギー治療市場規模は2033年までに14億6,150万米ドルに達する見込みです。

同市場は2025年から2033年にかけてCAGR 11.43％で成長すると予測されます。市場成長を促進する主な要因としては、堅調な製品パイプライン、高い疾患罹患率、ドラッグデリバリーシステムの進歩、主要企業による戦略的取り組みなどが挙げられます。

主要な市場参入企業は、さまざまな戦略を通じてピーナッツアレルギー治療のパイプラインを強化しています。例えば、アラバックスは2022年12月にシリーズBの資金調達ラウンドを開始し、オーストラリアの著名なヘルスケア起業家であるTenmileとBrandon Capitalから2,000万米ドルの投資を獲得しました。この資金調達により、アラバックスはピーナッツにアレルギー反応を起こす人を対象としたPVX108の第II相臨床試験を開始できるようになります。このような資金調達により、研究開発プログラムの進展が期待されます。

ピーナッツアレルギー治療薬の承認数が増加していることも市場を刺激しています。2020年1月、米国食品医薬品局（FDA）は、Aimmune Therapeutics, Inc.が開発したPALFORZIA[Peanut（Arachis hypogaea）Allergen Powder-dnfp]を認可しました。PALFORZIAは、ピーナッツ・アレルギーの患者さんに対して承認された初めての免疫療法薬です。本剤は、ピーナッツの誤食によるアナフィラキシーを含むアレルギー反応を軽減することを目的とした経口免疫療法剤です。本薬は、アレルギーが確認された患者を対象としており、4歳から17歳の小児には初回投与量の増量が推奨されています。

2023年第1四半期現在、いくつかの有望なパイプライン製品が臨床開発中です。DBVテクノロジーズのViaskin Peanut、DupixientのCA002、サノフィとリジェネロンの共同開発であるCamallegrなどです。さらに、ADP101、VE416、INP20、CNP-201などの資産も開発中です。これらの薬剤の導入は、予測期間中の市場の成長と拡大に貢献すると予想されます。

ピーナッツアレルギー治療市場のレポートハイライト

• エピネフリンセグメントが2024年の主要市場シェアを占めました。アナフィラキシー治療の標準はエピネフリン自動注射器であり、緊急時のアレルギー管理にも不可欠です。
• 投与経路別では、注射剤が2024年に市場を席巻しました。これは、患者中心の治療が重視されるようになり、患者にとって実用的で痛みが少なく、使いやすい注射剤治療の開発が進められているためです。これには、ウェアラブル技術や自動注射器など、注射療法の代替送達システムの検討も含まれます。
• 流通チャネル別では、病院薬局セグメントが2024年に最大の市場シェアを占めました。病院薬局はピーナッツアレルギーの患者へのサポートや情報提供に重点を置いています。
• 北米は同市場において確固たる地位を確立しています。これは、遺伝子治療、生物製剤、その他の免疫調節介入など、ピーナッツアレルギーの根本的な原因に対処するための新たな治療戦略を現在研究している数多くの製薬会社、学術機関、研究機関が存在するためです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 ピーナッツアレルギー治療市場の変数、動向、範囲

• 市場系統の見通し
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• ビジネス環境分析
  • 業界分析- ポーターのファイブフォース分析
  • PESTLE分析
  • パイプライン分析
  • 特許満了分析
  • 価格分析

第4章 ピーナッツアレルギー治療市場：薬剤クラスのビジネス分析

• 薬剤クラス市場シェア、2024年および2033年
• 薬剤クラスセグメントダッシュボード
• 市場規模と予測および動向分析（薬剤クラス別、2021～2033年）
• 抗ヒスタミン薬
• エピネフリン
• 免疫療法
• その他

第5章 ピーナッツアレルギー治療市場：投与経路のビジネス分析

• 投与経路市場シェア、2024年および2033年
• 投与経路セグメントダッシュボード
• 市場規模と予測および動向分析（薬剤クラス別、2021～2033年）
• 経口
• 注射剤
• その他

第6章 ピーナッツアレルギー治療市場：流通チャネルのビジネス分析

• 流通チャネル市場シェア、2024年および2033年
• 流通チャネルセグメントダッシュボード
• 市場規模、予測、動向分析（流通チャネル別、2021～2033年）
• 病院薬局
• 小売薬局
• その他

第7章 ピーナッツアレルギー治療市場：地域の推定・動向分析

• 地域別市場シェア分析、2024年および2033年
• 地域市場ダッシュボード
• 市場規模と予測動向分析、2021～2033年
• 北米
  • 国別、2021年～2033年
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東およびアフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 参加者概要
• 企業の市況分析
• 企業分類
• 戦略マッピング
• 企業プロファイル/上場企業
  • Aimmune Therapeutics（Nestle Health Science）
  • DBV Technologies
  • Sanofi
  • ALK-Abello
  • Prota Therapeutics
  • Camallergy
  • Aravax
  • Arch Pharmalabs
  • Genentech

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 Global Peanut Allergy Treatment market, by region, 2021 - 2033 (USD Million)
• Table 4 Global Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
• Table 5 Global Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
• Table 6 North America Peanut Allergy Treatment market, by country, 2021 - 2033 (USD Million)
• Table 7 North America Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
• Table 8 North America Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
• Table 9 U.S. Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
• Table 10 U.S. Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
• Table 11 Canada Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
• Table 12 Canada Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
• Table 13 Mexico Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
• Table 14 Mexico Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
• Table 15 Europe Peanut Allergy Treatment market, by country, 2021 - 2033 (USD Million)
• Table 16 Europe Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
• Table 17 Europe Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
• Table 18 UK Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
• Table 19 UK Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
• Table 20 Germany Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
• Table 21 Germany Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
• Table 22 France Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
• Table 23 France Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
• Table 24 Italy Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
• Table 25 Italy Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
• Table 26 Spain Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
• Table 27 Spain Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
• Table 28 Norway Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
• Table 29 Norway Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
• Table 30 Denmark Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
• Table 31 Denmark Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
• Table 32 Sweden Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
• Table 33 Sweden Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
• Table 34 Asia Pacific Peanut Allergy Treatment market, by country, 2021 - 2033 (USD Million)
• Table 35 Asia Pacific Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
• Table 36 Asia Pacific Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
• Table 37 Japan Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
• Table 38 Japan Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
• Table 39 China Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
• Table 40 China Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
• Table 41 India Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
• Table 42 India Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
• Table 43 Australia Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
• Table 44 Australia Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
• Table 45 South Korea Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
• Table 46 South Korea Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
• Table 47 Thailand Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
• Table 48 Thailand Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
• Table 49 Latin America Peanut Allergy Treatment market, by country, 2021 - 2033 (USD Million)
• Table 50 Latin America Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
• Table 51 Latin America Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
• Table 52 Brazil Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
• Table 53 Brazil Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
• Table 54 Argentina Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
• Table 55 Argentina Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
• Table 56 Middle East & Africa Peanut Allergy Treatment market, by country, 2021 - 2033 (USD Million)
• Table 57 Middle East & Africa Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
• Table 58 Middle East & Africa Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
• Table 59 South Africa Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
• Table 60 South Africa Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
• Table 61 Saudi Arabia Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
• Table 62 Saudi Arabia Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
• Table 63 UAE Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
• Table 64 UAE Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)
• Table 65 Kuwait Peanut Allergy Treatment market, by drug class, 2021 - 2033 (USD Million)
• Table 66 Kuwait Peanut Allergy Treatment market, by distribution channel, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 Peanut Allergy Treatment market segmentation
• Fig. 2 Market research process
• Fig. 3 Data triangulation techniques
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 Market formulation & validation
• Fig. 8 Market snapshot
• Fig. 9 Therapeutic approach and application outlook (USD Million)
• Fig. 10 Competitive landscape
• Fig. 11 Peanut Allergy Treatment market dynamics
• Fig. 12 Peanut Allergy Treatment market: Porter's five forces analysis
• Fig. 13 Peanut Allergy Treatment market: PESTLE analysis
• Fig. 14 Drug Class market, 2021 - 2033 (USD Million)
• Fig. 15 Antihistamines market, 2021 - 2033 (USD Million)
• Fig. 16 Epinephrine market, 2021 - 2033 (USD Million)
• Fig. 17 Immunotherapies market, 2021 - 2033 (USD Million)
• Fig. 18 Others market, 2021 - 2033 (USD Million)
• Fig. 19 Route of Administration market, 2021 - 2033 (USD Million)
• Fig. 20 Oral market, 2021 - 2033 (USD Million)
• Fig. 21 Injectable market, 2021 - 2033 (USD Million)
• Fig. 22 Others market, 2021 - 2033 (USD Million)
• Fig. 23 Distribution Channel market, 2021 - 2033 (USD Million)
• Fig. 24 Hospital Pharmacies market, 2021 - 2033 (USD Million)
• Fig. 25 Retail Pharmacies market, 2021 - 2033 (USD Million)
• Fig. 26 Others market, 2021 - 2033 (USD Million)
• Fig. 27 Peanut Allergy Treatment market revenue, by region
• Fig. 28 Regional marketplace: Key takeaways
• Fig. 29 North America Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
• Fig. 30 U.S. country dynamics
• Fig. 31 U.S. Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
• Fig. 32 Canada country dynamics
• Fig. 33 Canada Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
• Fig. 34 Mexico country dynamics
• Fig. 35 Mexico Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
• Fig. 36 Europe Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
• Fig. 37 UK country dynamics
• Fig. 38 UK Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
• Fig. 39 Germany country dynamics
• Fig. 40 Germany Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
• Fig. 41 France country dynamics
• Fig. 42 France Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
• Fig. 43 Italy country dynamics
• Fig. 44 Italy Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
• Fig. 45 Spain country dynamics
• Fig. 46 Spain Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
• Fig. 47 Norway country dynamics
• Fig. 48 Norway Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
• Fig. 49 Sweden country dynamics
• Fig. 50 Sweden Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
• Fig. 51 Denmark country dynamics
• Fig. 52 Denmark Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
• Fig. 53 Asia Pacific Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
• Fig. 54 Japan country dynamics
• Fig. 55 Japan Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
• Fig. 56 China country dynamics
• Fig. 57 China Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
• Fig. 58 India country dynamics
• Fig. 59 India Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
• Fig. 60 Australia country dynamics
• Fig. 61 Australia Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
• Fig. 62 South Korea country dynamics
• Fig. 63 South Korea Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
• Fig. 64 Thailand country dynamics
• Fig. 65 Thailand Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
• Fig. 66 Latin America Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
• Fig. 67 Brazil country dynamics
• Fig. 68 Brazil Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
• Fig. 69 Argentina country dynamics
• Fig. 70 Argentina Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
• Fig. 71 MEA Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
• Fig. 72 South Africa country dynamics
• Fig. 73 South Africa Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
• Fig. 74 Saudi Arabia country dynamics
• Fig. 75 Saudi Arabia Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
• Fig. 76 UAE country dynamics
• Fig. 77 UAE Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
• Fig. 78 Kuwait country dynamics
• Fig. 79 Kuwait Peanut Allergy Treatment market, 2021 - 2033 (USD Million)
• Fig. 80 Company categorization
• Fig. 81 Company market position analysis
• Fig. 82 Strategic framework

Peanut Allergy Treatment Market Growth & Trends:

The global peanut allergy treatment market size is expected to reach USD 1,461.5 million by 2033, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 11.43% from 2025 to 2033. Some of the key factors propelling the market growth include a robust product pipeline, high disease prevalence, advancement in the drug delivery system, and strategic initiatives by key players.

Key market players are bolstering their pipeline for peanut allergy treatment through various strategies. For instance, Aravax initiated its series B funding round in December 2022, securing a USD 20 million investment from renowned Australian healthcare entrepreneurs Tenmile and Brandon Capital. This financing will enable Aravax to commence phase II clinical trials of PVX108, targeting individuals who experience allergic reactions to peanuts. Such fundings are expected to drive advancements in research and development programs.

The market is stimulated by the increasing number of product approvals for peanut allergy treatment. In January 2020, the U.S. Food and Drug Administration (FDA) granted authorization to PALFORZIA [Peanut (Arachis hypogaea) Allergen Powder-dnfp], developed by Aimmune Therapeutics, Inc. PALFORZIA is the first immunotherapy medication approved for individuals with peanut allergies. It is an oral immune therapy designed to reduce allergy responses, including anaphylaxis triggered by accidental peanut ingestion. It is intended for individuals who have a confirmed allergy, with initial dose escalation recommended for children aged four to 17.

As of the first quarter of 2023, several promising pipeline products are undergoing clinical development. These include Viaskin Peanut by DBV Technologies, CA002 by Dupixient, and Camallegr, a collaborative effort between Sanofi and Regeneron. Additionally, other assets such as ADP101, VE416, INP20, and CNP-201 are also in development. The introduction of these medications is anticipated to contribute to the growth and expansion of the market during the projected forecast period.

Peanut Allergy Treatment Market Report Highlights:

• The epinephrine segment held the major market share in 2024. The standard of care for anaphylaxis treatment has been epinephrine auto-injectors, which are also essential in the management of allergies in emergency situations.
• By route of administration, the injectable segment dominated the market in 2024 owing to the development of injectable treatments that are practical, less painful, and easier to use for patients is being pursued in response to the growing emphasis on patient-centered care. This includes looking at alternative delivery systems for injectable therapies, such as wearable technology or auto-injectors.
• By distribution channel, the hospital pharmacy segment held the largest market share in 2024. Hospital pharmacies put more of an emphasis on offering patient support and information for people with peanut allergies.
• North America has established a strong regional position in the market. This is due to the presence of numerous pharmaceutical companies, academic institutions, and research organizations currently looking into new therapeutic strategies to address the underlying causes of peanut allergies, including gene therapy, biologics, and other immunomodulatory interventions.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Drug Class
  • 1.2.2. Route of Administration
  • 1.2.3. Distribution Channel
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Peanut Allergy Treatment Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrants
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTLE Analysis
  • 3.3.3. Pipeline Analysis
  • 3.3.4. Patent Expiry Analysis
  • 3.3.5. Pricing Analysis

Chapter 4. Peanut Allergy Treatment Market: Drug Class Business Analysis

• 4.1. Drug Class Market Share, 2024 & 2033
• 4.2. Drug Class Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Drug Class, 2021 to 2033 (USD Million)
• 4.4. Antihistamines
  • 4.4.1. Antihistamines Market, 2021 - 2033 (USD Million)
• 4.5. Epinephrine
  • 4.5.1. Epinephrine Market, 2021 - 2033 (USD Million)
• 4.6. Immunotherapies
  • 4.6.1. Immunotherapies Market, 2021 - 2033 (USD Million)
• 4.7. Others
  • 4.7.1. Others Market, 2021 - 2033 (USD Million)

Chapter 5. Peanut Allergy Treatment Market: Route of Administration Business Analysis

• 5.1. Route of Administration Market Share, 2024 & 2033
• 5.2. Route of Administration Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analysis, by Drug Class, 2021 to 2033 (USD Million)
• 5.4. Oral
  • 5.4.1. Oral Market, 2021 - 2033 (USD Million)
• 5.5. Injectable
  • 5.5.1. Injectable Market, 2021 - 2033 (USD Million)
• 5.6. Others
  • 5.6.1. Others Market, 2021 - 2033 (USD Million)

Chapter 6. Peanut Allergy Treatment Market: Distribution Channel Business Analysis

• 6.1. Distribution Channel Market Share, 2024 & 2033
• 6.2. Distribution Channel Segment Dashboard
• 6.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
• 6.4. Hospital Pharmacies
  • 6.4.1. Hospital Pharmacies Market, 2021 - 2033 (USD Million)
• 6.5. Retail Pharmacies
  • 6.5.1. Retail Pharmacies Market, 2021 - 2033 (USD Million)
• 6.6. Others
  • 6.6.1. Others Market, 2021 - 2033 (USD Million)

Chapter 7. Peanut Allergy Treatment Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2024 & 2033
• 7.2. Regional Market Dashboard
• 7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
• 7.4. North America
  • 7.4.1. North America Peanut Allergy Treatment Market Estimates And Forecasts, By Country, 2021 - 2033 (USD Million)
  • 7.4.2. U.S.
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Target Disease Prevalence
    • 7.4.2.3. Regulatory Framework
    • 7.4.2.4. Reimbursement Framework
    • 7.4.2.5. U.S. Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.3. Canada
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Target Disease Prevalence
    • 7.4.3.3. Regulatory Framework
    • 7.4.3.4. Reimbursement Framework
    • 7.4.3.5. U.S. Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.4. Mexico
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Target Disease Prevalence
    • 7.4.4.3. Regulatory Framework
    • 7.4.4.4. Reimbursement Framework
    • 7.4.4.5. Mexico Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.5. Europe
  • 7.5.1. Europe Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.2. UK
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Target Disease Prevalence
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. Reimbursement Framework
    • 7.5.2.5. Uk Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.3. Germany
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Target Disease Prevalence
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. Reimbursement Framework
    • 7.5.3.5. Germany Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.4. France
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Target Disease Prevalence
    • 7.5.4.3. Regulatory Framework
    • 7.5.4.4. Reimbursement Framework
    • 7.5.4.5. France Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.5. Italy
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Target Disease Prevalence
    • 7.5.5.3. Regulatory Framework
    • 7.5.5.4. Reimbursement Framework
    • 7.5.5.5. Italy Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.6. Spain
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Target Disease Prevalence
    • 7.5.6.3. Regulatory Framework
    • 7.5.6.4. Reimbursement Framework
    • 7.5.6.5. Spain Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.7. Denmark
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Target Disease Prevalence
    • 7.5.7.3. Regulatory Framework
    • 7.5.7.4. Reimbursement Framework
    • 7.5.7.5. Denmark Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.8. Sweden
    • 7.5.8.1. Key Country Dynamics
    • 7.5.8.2. Target Disease Prevalence
    • 7.5.8.3. Regulatory Framework
    • 7.5.8.4. Reimbursement Framework
    • 7.5.8.5. Sweden Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.9. Norway
    • 7.5.9.1. Key Country Dynamics
    • 7.5.9.2. Target Disease Prevalence
    • 7.5.9.3. Regulatory Framework
    • 7.5.9.4. Reimbursement Framework
    • 7.5.9.5. Norway Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.2. Japan
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Target Disease Prevalence
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Reimbursement Framework
    • 7.6.2.5. Japan Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.3. China
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Target Disease Prevalence
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. Reimbursement Framework
    • 7.6.3.5. China Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.4. India
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Target Disease Prevalence
    • 7.6.4.3. Regulatory Framework
    • 7.6.4.4. Reimbursement Framework
    • 7.6.4.5. India Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.5. Australia
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Target Disease Prevalence
    • 7.6.5.3. Regulatory Framework
    • 7.6.5.4. Reimbursement Framework
    • 7.6.5.5. Australia Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.6. South Korea
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Target Disease Prevalence
    • 7.6.6.3. Regulatory Framework
    • 7.6.6.4. Reimbursement Framework
    • 7.6.6.5. South Korea Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.7. Thailand
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Target Disease Prevalence
    • 7.6.7.3. Regulatory Framework
    • 7.6.7.4. Reimbursement Framework
    • 7.6.7.5. Thailand Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.7. Latin America
  • 7.7.1. Latin America Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Target Disease Prevalence
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. Reimbursement Framework
    • 7.7.2.5. Japan Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Target Disease Prevalence
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. Reimbursement Framework
    • 7.7.3.5. China Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.8. Middle East and Africa
  • 7.8.1. Middle East and Africa Peanut Allergy Treatment Market Estimates and Forecasts, 2017 - 2030 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Target Disease Prevalence
    • 7.8.2.3. Regulatory Framework
    • 7.8.2.4. Reimbursement Framework
    • 7.8.2.5. South Africa Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Target Disease Prevalence
    • 7.8.3.3. Regulatory Framework
    • 7.8.3.4. Reimbursement Framework
    • 7.8.3.5. Saudi Arabia Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. Key Country Dynamics
    • 7.8.4.2. Target Disease Prevalence
    • 7.8.4.3. Regulatory Framework
    • 7.8.4.4. Reimbursement Framework
    • 7.8.4.5. UAE Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key Country Dynamics
    • 7.8.5.2. Target Disease Prevalence
    • 7.8.5.3. Regulatory Framework
    • 7.8.5.4. Reimbursement Framework
    • 7.8.5.5. Kuwait Peanut Allergy Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Participant Overview
• 8.2. Company Market Position Analysis
• 8.3. Company Categorization
• 8.4. Strategy Mapping
• 8.5. Company Profiles/Listing
  • 8.5.1. Aimmune Therapeutics (Nestle Health Science)
    • 8.5.1.1. Overview
    • 8.5.1.2. Financial Performance
    • 8.5.1.3. Product Benchmarking
    • 8.5.1.4. Strategic Initiatives
  • 8.5.2. DBV Technologies
    • 8.5.2.1. Overview
    • 8.5.2.2. Financial Performance
    • 8.5.2.3. Product Benchmarking
    • 8.5.2.4. Strategic Initiatives
  • 8.5.3. Sanofi
    • 8.5.3.1. Overview
    • 8.5.3.2. Financial Performance
    • 8.5.3.3. Product Benchmarking
    • 8.5.3.4. Strategic Initiatives
  • 8.5.4. ALK-Abello
    • 8.5.4.1. Overview
    • 8.5.4.2. Financial Performance
    • 8.5.4.3. Product Benchmarking
    • 8.5.4.4. Strategic Initiatives
  • 8.5.5. Prota Therapeutics
    • 8.5.5.1. Overview
    • 8.5.5.2. Financial Performance
    • 8.5.5.3. Product Benchmarking
    • 8.5.5.4. Strategic Initiatives
  • 8.5.6. Camallergy
    • 8.5.6.1. Overview
    • 8.5.6.2. Financial Performance
    • 8.5.6.3. Product Benchmarking
    • 8.5.6.4. Strategic Initiatives
  • 8.5.7. Aravax
    • 8.5.7.1. Overview
    • 8.5.7.2. Financial Performance
    • 8.5.7.3. Product Benchmarking
    • 8.5.7.4. Strategic Initiatives
  • 8.5.8. Arch Pharmalabs
    • 8.5.8.1. Overview
    • 8.5.8.2. Financial Performance
    • 8.5.8.3. Product Benchmarking
    • 8.5.8.4. Strategic Initiatives
  • 8.5.9. Genentech
    • 8.5.9.1. Overview
    • 8.5.9.2. Financial Performance
    • 8.5.9.3. Product Benchmarking
    • 8.5.9.4. Strategic Initiatives